FDA, COVID
Digest more
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.
President Donald Trump’s administration is slated to lay out its approach to Covid vaccination at an event Tuesday that could spell major changes in what is required to get regulatory approval for immunizations.
Explore more